Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 17, Issue 3, Pages 457-468Publisher
IOS PRESS
DOI: 10.3233/JAD-2009-1068
Keywords
Alzheimer's disease; clioquinol; cuprizone; metal dishomeostasis; metal ions; nanomedicine; Parkinson's disease; polyphenols
Categories
Funding
- Council for Scientific and Industrial Research, India
- the Italian Minister of Research and University [RBNEOPX83]
- NIH [AG023055]
Ask authors/readers for more resources
A close association between brain metal dishomeostasis and the onset and/or progression of Alzheimer's disease ( AD) has been clearly established in a number of studies, although the underlying biochemical mechanisms remain obscure. This observation renders chelation therapy an attractive pharmacological option for the treatment of this disease. However, a number of requirements must be fulfilled in order to adapt chelation therapy to AD so that the term metal targeted strategies seems now more appropriate. Indeed, brain metal redistribution rather than brain metal scavenging and removal is the major goal of this type of intervention. The most recent developments in metal targeted strategies for AD will be discussed using, as useful examples, clioquinol, curcumin, and epigallocatechin, and the future perspectives will also be outlined.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available